STOK (Stoke Corp) Tambahing bathi saben saham ing taun lumaku
Stoke Therapeutics (STOK) is developing RNA therapies to combat rare genetic pathologies, which confirms a shift in earnings per share compared to last year; the -3212.70 metric determines this level. Business success is based on clinical trial results and patent protection. Monetization relies on scientific collaborations and licensing agreements without conducting merger and acquisition deals.
Rincian analitis lan laporan data perusahaan Stoke Therapeutics (STOK)
- rega saham lan prakiraan rega para ahli:
- indikator valuasi pasar bisnis:
- rincian valuasi buku bisnis:
- indikator beban utang lan likuiditas:
Total Utang marang Modal Stoke Therapeutics|STOK - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas stoketherapeutics.com|STOK - Gunggung utang perusahaan|Utang-utang marang nilai buku Stoke Corp|STOK - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Stoke Therapeutics|Rasio likuiditas perantara stoketherapeutics.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
STOK - Bathi resik|Prakiraan bathi perusahaan Stoke Therapeutics|STOK - Pangali P/E|Prakiraan rega marang bathi Stoke Corp|STOK - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Stoke Corp|STOK - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Stoke Therapeutics|STOK - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan stoketherapeutics.com|STOK - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Stoke Therapeutics
- data pendapatan lan penerimaan dodolan:
Pambiji fundamental:STOK Stoke Therapeutics Inc
Stoke Therapeutics (STOK) is developing a closed RNA therapy ecosystem, where proprietary gene expression regulation creates a high dependency of clinics on the company's drugs. An analysis of the relative growth of net earnings per share over the year allows for an assessment of the monetization efficiency of this technology and the business's ability to scale profitability, which serves as a key indicator of the fundamental stability of capitalization amid market revaluation.
Pesaing wigati
TEM: Wutah bathi resik saben siji saham kanggo taun lumaku|QGEN (Qiagen Group) - Wutah bathi ing taun lumaku|IONS: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku RGEN|RNA - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku CRISPR Therapeutics CRSP|Tambahing bathi saben saham ing taun lumaku WGS|Ultragenyx Pharma - Wutah bathi ing taun lumaku|BEAM - Wutah bathi ing taun lumaku|Sarepta Therapeutics, Inc. (SRPT) - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku TWST (twistbioscience.com)|TXG (10x Genomics) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Intellia Therapeutics Inc NTLA|Wutah bathi resik saben saham ing taun iki BLFS (BioLife Corp)|Wutah bathi ing taun lumaku Wave Pharma (WVE)|Maze Therapeutics Inc - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku SION (sionnatx.com)|Prime Medicine - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Taysha Gene Therapies Inc TSHA|QURE: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki MeiraGTx Corp|Wutah bathi saben saham ing taun lumaku REGENXBIO Inc.|solidbio.com (SLDB) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Ocugen (OCGN)|Prakiraan wutah bathi resik saben saham ing taun iki Pacific Biosciences of California, Inc.|Benitec - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku DSGN (Design Corp)|RCKT - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku 4dmoleculartherapeutics.com|lexeotx.com (LXEO) - Wutah bathi saben saham ing taun lumaku|Korro Bio (KRRO) - Wutah bathi ing taun lumaku|EDIT (Editas) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki SLN (Silence Therapeutics Corp)|Wutah bathi saben saham ing taun lumaku ProQR Therapeutics N.V. (PRQR)|codexis.com - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku SGMO (Sangamo Therapeutics, Inc.)|Wutah bathi ing taun lumaku Nautilus Biotechnology, Inc. NAUT|MGX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki precisionbiosciences.com DTIL|GBIO (generationbio.com) - Wutah bathi resik saben saham ing taun iki|BOLD: Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi saben saham ing taun lumaku Exicure Inc.|Kacepetan wutah bathi saben saham ing taun lumaku Celsion Corporation IMNN|Wutah bathi saben saham ing taun lumaku Phio Pharmaceuticals (PHIO)|Wutah bathi ing taun lumaku mustangbio.com (MBIO)|Wutah bathi ing taun lumaku RNAZ (TransCode Therapeutics, Inc.)|Bionano Genomics Inc. (BNGO) - Kacepetan wutah bathi saben saham ing taun lumaku|APDN: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku BLUE (bluebird bio Inc.)|IPA (immunoprecise.com) - Wutah bathi resik saben saham ing taun iki|OMGA: Wutah bathi resik saben siji saham kanggo taun lumaku|OMIC (Singular Genomics Systems) - Wutah bathi ing taun lumaku|RGLS: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku SYRS|TBIO - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku TRACON TCON|Tambahing bathi saben saham ing taun lumaku UBX
